ATP1B2 Protein is a protein encoded by the [ATP1B2](/genes/atp1b2) gene. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Structure
ATP1B2 is a beta subunit of the Na+/K+ ATPase complex:
Single transmembrane domain: Anchors the protein in the plasma membrane
Extracellular loop: Contains disulfide bonds important for assembly with the alpha subunit
Intracellular N-terminus: Short cytoplasmic domain involved in regulation
Glycosylation sites: N-linked glycosylation in the extracellular domain
ATP1B2 Protein is a protein encoded by the [ATP1B2](/genes/atp1b2) gene. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Structure
ATP1B2 is a beta subunit of the Na+/K+ ATPase complex:
Single transmembrane domain: Anchors the protein in the plasma membrane
Extracellular loop: Contains disulfide bonds important for assembly with the alpha subunit
Intracellular N-terminus: Short cytoplasmic domain involved in regulation
Glycosylation sites: N-linked glycosylation in the extracellular domain
The beta subunit is essential for proper folding, trafficking, and stability of the Na+/K+ ATPase complex in the plasma membrane.
Normal Function in the Nervous System
ATP1B2 is critical for neuronal ion homeostasis:
Ion gradient maintenance: Partners with ATP1A subunits to establish Na+ and K+ gradients
Resting membrane potential: Essential for maintaining neuronal resting potential
Neurotransmitter uptake: Drives secondary active transport of neurotransmitters
Synaptic function: Maintains ionic conditions for synaptic transmission
Astrocyte function: Highly expressed in [astrocytes](/entities/astrocytes) for potassium buffering
In the brain, ATP1B2 is expressed predominantly in [neurons](/entities/neurons) and astrocytes, where it maintains the ionic homeostasis essential for proper neurological function.
Role in Neurodegeneration
ATP1B2 dysfunction is implicated in several neurodegenerative conditions:
Alzheimer's Disease
Reduced ATP1B2 expression in AD brains correlates with cognitive decline
Impaired Na+/K+ ATPase activity contributes to excitotoxicity
[Beta-amyloid](/proteins/amyloid-beta) directly inhibits ATP1B2 function
Therapeutic targeting of Na+/K+ ATPase shows promise in AD models
Parkinson's Disease
ATP1B2 dysfunction contributes to dopaminergic neuron vulnerability
Impaired ion homeostasis in PD models involves ATP1B2
Energy failure in PD involves reduced Na+/K+ ATPase activity
Amyotrophic Lateral Sclerosis (ALS)
Altered ATP1B2 expression in ALS motor neurons
Energy metabolism deficits in ALS involve ion pump dysfunction
Epilepsy
ATP1B2 mutations cause epileptic encephalopathy
Impaired ionic gradients lead to hyperexcitability
Therapeutic Targeting
Current therapeutic strategies:
Na+/K+ ATPase activators: Cardiac glycosides indirectly enhance function
Gene therapy: AAV-mediated ATP1B2 delivery being explored
Small molecule stabilizers: Compounds that stabilize the ATP1B2 structure
Protein replacement: Not yet feasible due to membrane protein complexity